Dr. Lal PathLabs informs about closure of trading window

25 Jan 2024 Evaluate
Dr. Lal PathLabs has informed that a meeting of the Board of Directors is scheduled to be held on Thursday, February 01, 2024 to consider and approve the Un-audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Nine Months ended December 31, 2023 and to consider the proposal of declaration of 2nd interim dividend, if any, on the equity shares of the Company for the Financial Year 2023-24. Further, in continuation to letter dated December 26, 2023 and in line with the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's code for Prevention of Insider Trading, the Trading Window for dealing in Securities of the Company is closed and shall re-open after 48 hours from the declaration of the aforesaid Financial Results.

The above information is a part of company’s filings submitted to BSE.

Dr. Lal Pathlabs Share Price

2953.35 -67.15 (-2.22%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7248.75
Max Healthcare Inst 1166.60
Narayana Hrudayalay 1286.30
Aster DM Healthcare 486.85
Global Health 1098.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.